Calithera Biosciences, Inc.

CIK 1496671 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Calithera Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Jun 15, 2023CT ORDER9999999997-23-003173
Jun 5, 2023DEFM14A0001140361-23-028417
May 26, 2023PREM14A0001140361-23-026989
May 26, 202340001395064-23-000040
May 26, 2023SC 13D/A0001395064-23-000042
May 22, 2023DEFA14A0001193125-23-149629
Mar 31, 202310-K0000950170-23-011047
Mar 17, 2023EFFECT9999999995-23-000597
Mar 14, 2023S-8 POS0001193125-23-070147
Mar 14, 2023S-8 POS0001193125-23-070150
Mar 14, 2023S-8 POS0001193125-23-070145
Mar 14, 2023S-8 POS0001193125-23-070129
Mar 14, 2023S-8 POS0001193125-23-070152
Mar 14, 2023POS AM0001193125-23-070124
Mar 14, 2023S-8 POS0001193125-23-070155
Mar 14, 202315-12G0001193125-23-070159
Mar 14, 2023S-8 POS0001193125-23-070138
Mar 14, 2023S-8 POS0001193125-23-070142
Mar 14, 2023S-8 POS0001193125-23-070136
Mar 3, 202325-NSE0001354457-23-000146
Feb 14, 2023SC 13G/A0000921895-23-000527
Feb 14, 2023SC 13G/A0001104659-23-020709
Feb 9, 2023SC 13G/A0001085146-23-000907
Feb 9, 2023SC 13G/A0001085146-23-000894
Feb 8, 2023SC 13G/A0001104659-23-014522